Whitman-Walker Institute ( Site 1538) — Washington D.C., District of Columbia

Whitman-Walker Institute ( Site 1538) is a clinical research site located in Washington D.C., District of Columbia, United States 20032.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Whitman-Walker Institute ( Site 1538) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Human Immunodeficiency Virus Type 1 (HIV-1) Infection.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Whitman-Walker Institute ( Site 1538)?

Whitman-Walker Institute ( Site 1538) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Whitman-Walker Institute ( Site 1538) conducted?

Whitman-Walker Institute ( Site 1538) has 1 clinical trials on record, with 1 currently active. Their work covers Human Immunodeficiency Virus Type 1 (HIV-1) Infection.

Is Whitman-Walker Institute ( Site 1538) accredited by Crixeo Health?

Whitman-Walker Institute ( Site 1538) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Whitman-Walker Institute ( Site 1538)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.